|
|
|
|
| LEADER |
01899nam a2200325 u 4500 |
| 001 |
EB001999930 |
| 003 |
EBX01000000000000001162831 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 020 |
|
|
|a 9789240013933
|
| 020 |
|
|
|a 9789240013926
|
| 245 |
0 |
0 |
|a WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth
|h Elektronische Ressource
|
| 260 |
|
|
|a Geneva, Switzerland
|b World Health Organization
|c [2020], 2020
|
| 300 |
|
|
|a 1 PDF file (ix, 39 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Evidence-Based Medicine / standards
|
| 653 |
|
|
|a Oxytocin / administration & dosage
|
| 653 |
|
|
|a Oxytocin / therapeutic use
|
| 653 |
|
|
|a Postpartum Hemorrhage / drug therapy
|
| 653 |
|
|
|a Drug Administration Routes
|
| 710 |
2 |
|
|a World Health Organization
|
| 710 |
2 |
|
|a Special Programme of Research, Development, and Research Training in Human Reproduction (World Health Organization)
|
| 710 |
2 |
|
|a World Health Organization
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK564756
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a In 2019, the Executive Guideline Steering Group (GSG) for World Health Organization (WHO) maternal and perinatal health recommendations prioritized the updating of the existing WHO recommendations for intravenous (IV) versus intramuscular (IM) oxytocin for prevention of PPH after vaginal birth in response to the availability of new evidence. The recommendation in this document thus supersedes the previous WHO recommendations for the prevention of PPH as published in the 2012 guideline: WHO recommendations for the prevention and treatment of postpartum haemorrhage
|